PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 708 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 708 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 708 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 708 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 708 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 708 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 708 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 708 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 708 | +76.6% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 401 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -99.7% | 401 | -99.6% | 0.00% | -100.0% |
| Q4 2020 | $985,000 | +189.7% | 96,549 | -0.7% | 0.01% | +166.7% |
| Q3 2020 | $340,000 | +34.9% | 97,218 | +90.9% | 0.00% | -40.0% |
| Q2 2020 | $252,000 | -56.6% | 50,918 | -70.2% | 0.01% | -16.7% |
| Q1 2020 | $581,000 | – | 170,918 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |